213 related articles for article (PubMed ID: 10461064)
1. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
Kawate S; Fukusato T; Ohwada S; Watanuki A; Morishita Y
Oncology; 1999; 57(2):157-63. PubMed ID: 10461064
[TBL] [Abstract][Full Text] [Related]
2. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella A; Gramlich T; Fritsch C; Gansler T
Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
Wu B; Wang M; You W; Yang S
Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.
Saegusa M; Takano Y; Kishimoto H; Wakabayashi G; Nohga K; Okudaira M
J Cancer Res Clin Oncol; 1993; 119(12):737-44. PubMed ID: 8104947
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization].
Fang Y; Huang B; Liang Q; Li H; Huang C
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):180-2. PubMed ID: 11866973
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.
Jang KY; Noh SJ; Lehwald N; Tao GZ; Bellovin DI; Park HS; Moon WS; Felsher DW; Sylvester KG
PLoS One; 2012; 7(9):e45119. PubMed ID: 23024800
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
10. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A
Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance.
Peng SY; Lai PL; Hsu HC
J Formos Med Assoc; 1993 Oct; 92(10):866-70. PubMed ID: 7511953
[TBL] [Abstract][Full Text] [Related]
12. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
13. Low MIB-1 labeling index in anti-HCV positive hepatocellular carcinoma.
Watanuki A; Ohwada S; Fukusato T; Kawate S; Makita F; Morishita Y
Int J Oncol; 1998 Nov; 13(5):1017-22. PubMed ID: 9772294
[TBL] [Abstract][Full Text] [Related]
14. Correlation between clinical characteristics, survival and genetic alterations in patients with hepatocellular carcinoma from Saudi Arabia.
Al-Qahtani A; Al-Hazzani T; Al-hussain T; Al-Ghamdi A; Al-Mana H; Al-Arifi S; Al-Ahdal M; Aly M
Cancer Genet Cytogenet; 2010 Dec; 203(2):269-77. PubMed ID: 21156243
[TBL] [Abstract][Full Text] [Related]
15. [c-myc gene and p53 protein expression in human primary liver carcinoma].
Cai DW; Gao CZ; Wang NJ
Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):100-3. PubMed ID: 8082236
[TBL] [Abstract][Full Text] [Related]
16. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
Yang S; Wang M; You W
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
[TBL] [Abstract][Full Text] [Related]
17. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
18. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.
Tantiwetrueangdet A; Panvichian R; Sornmayura P; Leelaudomlipi S; Macoska JA
BMC Cancer; 2021 Mar; 21(1):295. PubMed ID: 33743635
[TBL] [Abstract][Full Text] [Related]
19. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and amplification of c-myc during progression of human colorectal cancer.
Rochlitz CF; Herrmann R; de Kant E
Oncology; 1996; 53(6):448-54. PubMed ID: 8960139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
